

Nexus Drugs Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 2.00 Cr
- Company Age 24 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.11 Cr
- Revenue Growth -41.60%
- Profit Growth 23.09%
- Ebitda -11.00%
- Net Worth 0.61%
- Total Assets -11.68%
About Nexus Drugs
Nexus Drugs Private Limited (NDPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 02 February 2001 and has a history of 24 years and one month. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹2.11 Cr.
Suresh Kilaru, Ramakrishna Gadipudi, and Mallikarjun Koyilakonda serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24243TG2001PTC036160
- Company No.
036160
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Feb 2001
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Nexus Drugs?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Suresh Kilaru ![]() | Director | 13-Aug-2020 | Current |
Ramakrishna Gadipudi ![]() | Director | 08-Feb-2017 | Current |
Mallikarjun Koyilakonda | Director | Current |
Financial Performance of Nexus Drugs.
Nexus Drugs Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 41.6% decrease. The company also saw a substantial improvement in profitability, with a 23.09% increase in profit. The company's net worth moved up by a moderate rise of 0.61%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Nexus Drugs?
In 2023, Nexus Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- Rajan Dairy Llp
Suresh Kilaru is a mutual person
- Reyan Buildwell India Private Limited
Suresh Kilaru is a mutual person
- Elite Electoral Calculus Private Limited
Suresh Kilaru is a mutual person
- Sonalini Secure Print Private Limited
Ramakrishna Gadipudi is a mutual person
- Svr Pharmatech Private Limited
Ramakrishna Gadipudi is a mutual person
- Svr Api Private Limited
Ramakrishna Gadipudi is a mutual person
Charges (Loans)
₹2.11 Cr
₹0
Charges Breakdown by Lending Institutions
- Andhra Bank : 2.11 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
14 Feb 2012 | Andhra Bank | ₹1.11 Cr | Open |
22 Dec 2009 | Andhra Bank | ₹1.00 Cr | Open |
How Many Employees Work at Nexus Drugs?
Unlock and access historical data on people associated with Nexus Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Nexus Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nexus Drugs's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Nexus Drugs
Recent activity within the organization
- Annual General Meeting
Nexus Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
- Balance Sheet
Nexus Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
- Director Appointment
Suresh Kilaru was appointed as a Director was appointed as a Director on 13 Aug 2020 & has been associated with this company since 4 years 7 months .
- Director Appointment
Ramakrishna Gadipudi was appointed as a Director was appointed as a Director on 08 Feb 2017 & has been associated with this company since 8 years 1 month .
- Charges
A charge with Andhra Bank of Rs. 1.11 Cr registered on 14 Feb 2012 with Charge ID 10341791 was modified on 13 Dec 2013.
- Charges
A charge with Andhra Bank amounted to Rs. 1.11 Cr with Charge ID 10341791 was registered on 14 Feb 2012.
Frequently asked questions
What is the Incorporation or founding date of Nexus Drugs Private Limited?
Nexus Drugs Private Limited was incorporated on 02 Feb 2001.
What is authorized share capital and paid-up capital of Nexus Drugs Private Limited?
The authorized share capital of Nexus Drugs Private Limited is ₹ 2.00 Cr and paid-up capital is ₹ 2.00 Cr.
Who are the current board members & directors of Nexus Drugs Private Limited?
Currently 3 directors are associated with Nexus Drugs Private Limited.
- Suresh Kilaru
- Ramakrishna Gadipudi
- Mallikarjun Koyilakonda
What is the registered address of Nexus Drugs Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Nexus Drugs Private Limited is Plot No 34 Flat 201 Magistic Chambers East Srinivas Nagar, S R Nagar India, Hyderabad, Telangana, 500038.
What is the corporate identification number (CIN) and company number of Nexus Drugs Private Limited?
The corporate identification number (CIN) of Nexus Drugs Private Limited is U24243TG2001PTC036160 and the company number is 036160 as per Ministry of Corporate Affairs (MCA).
What is the official website of Nexus Drugs Private Limited?
The Official website of Nexus Drugs Private Limited is https://www.nexusdrugs.com
What has been the recent revenue trend for Nexus Drugs Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Nexus Drugs Private Limited has fallen by -41.60%.
What change has been observed in the net worth of Nexus Drugs Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Nexus Drugs Private Limited has experienced an upsurge of 0.61%.
What are the total open charges for Nexus Drugs Private Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Nexus Drugs Private Limited amount to ₹ 2.11 Cr.
When was the last Balance Sheet of Nexus Drugs Private Limited filed with the ROC?
The most recent Balance Sheet for Nexus Drugs Private Limited was filed with the ROC on 31 Mar 2023.
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
PR
Parasa RaoDirectorNP
Nannuri PrasannaDirectorKS
Ketina SatyanarayanaDirectorVD
Venkateswara DagupatiDirectorSC
Suresh ChilakalpudiDirectorNR
Nageshwar RaoDirectorSG
Sreenivasulu GonuguntlaDirectorPG
Poornima GadipudiDirector